Wandong Medical (600055) 2021 Third Quarter Report Review: Revenue Side Achieves Higher Growth Product Structure Changes Pressure Profit Side
Wandong Medical (600055): Product market demand returns to normal, benefiting from new medical infrastructure in the long term
Wandong Medical (600055) 2020 Annual Report and 2021 Quarterly Report Reviews: Mobile DR Drives Full-Year 2020 Growth, 21Q1 Performance Is Under Strong Pressure
万东医疗(600055):DR类产品需求贯穿全年 常规产品业绩逐步回暖
Wandong Medical (600055): improved month-on-month ratio of conventional products
万东医疗(600055):Q3营收同比下降 长期受益于医疗新基建
万东医疗(600055)2020中报点评:抗疫相关产品实现高增长 其他产品业绩逐步回暖
Wandong Medical (600055): high performance growth is expected to benefit from the policy of increasing medical equipment configuration certificates.
万东医疗(600055)2020半年报点评:抗疫DR表现亮眼 毛利率提升明显
Wandong Medical (600055): anti-epidemic products shine brilliantly
万东医疗(600055):DR及移动DR持续靓丽
万东医疗(600055)2019年年报及2020年一季报点评:抗疫产品Q1高增长 产品结构持续升级
万东医疗(600055)年报点评报告:2019业绩稳健增长 受疫情影响2020Q1利润剧增
Wandong Medical (600055): Rapid growth in performance in the first quarter, new infrastructure further boosts equipment demand
万东医疗(600055)年报点评:2019表现平稳 疫情推动影像诊断产品需求
万东医疗(600055):2019年经营效率持续提升 2020Q1业绩表现突出
万东医疗(600055)2019年报暨2020Q1季报点评:疫情激增移动DR需求 业绩表现亮眼
Wandong Medical (600055): the whole product line layout of medical image scarcity has a broad prospect.
万东医疗(600055):抗疫先锋 移动DR勇担大任
万东医疗(600055):外资投资评级(FIR)